227 related articles for article (PubMed ID: 10292027)
1. Who's deciding whether to overrule your prescriptions?
Schutte JE
Med Econ; 1989 Mar; 66(5):50-5. PubMed ID: 10292027
[No Abstract] [Full Text] [Related]
2. Liability at issue as firms target drug costs.
Kenkel PJ
Mod Healthc; 1990 Aug; 20(34):41. PubMed ID: 10105826
[No Abstract] [Full Text] [Related]
3. Perspectives. Drug formularies pose legal threat to providers.
Moskowitz DB
Faulkner Grays Med Health; 1995 Feb; 49(6):suppl 1-4. PubMed ID: 10139750
[No Abstract] [Full Text] [Related]
4. HMOs try formularies in effort to curb prescription costs.
Feldman A
Contract Healthc; 1988 Jul; ():33-5. PubMed ID: 10290628
[No Abstract] [Full Text] [Related]
5. Getting serious about generics.
Sipkoff M
Manag Care; 2003 Jan; 12(1):36-9. PubMed ID: 12575509
[No Abstract] [Full Text] [Related]
6. Coalition fights substituting drugs without physician OK.
Pollner F
Med World News; 1989 Apr; 30(7):20-1. PubMed ID: 10292641
[No Abstract] [Full Text] [Related]
7. Generics--is the price too high?
Marshall WJ
Ohio State Med J; 1986 Apr; 82(4):261-3, 265. PubMed ID: 3703433
[No Abstract] [Full Text] [Related]
8. Rx cost control: what's your role?
Guglielmo WJ
Med Econ; 2003 Feb; 80(4):27-8, 31-2. PubMed ID: 12666646
[No Abstract] [Full Text] [Related]
9. FDA drug list: key to generic substitution.
FDA Consum; 1979 Feb; 13(1):15-7. PubMed ID: 10308816
[TBL] [Abstract][Full Text] [Related]
10. Prescribing practices of physicians affiliated with multiple formularies.
Haymes A; Dietze D
AAPPO J; 1991; 1(5):9-14. PubMed ID: 10149639
[No Abstract] [Full Text] [Related]
11. Prescriptions enter the political arena.
Regier H
J Leg Med (N Y); 1974; 2(2):24-30. PubMed ID: 4545342
[No Abstract] [Full Text] [Related]
12. Formularies tighten and physicians adapt.
Lawrence J
Manag Care; 1998 Mar; 7(3):23-6, 29-30. PubMed ID: 10177957
[No Abstract] [Full Text] [Related]
13. Generic vs. brand name drugs--patients, pharmacists, physicians: caught in the middle.
Felch WC
Internist; 1979 May; 20(4):3-5. PubMed ID: 10242131
[No Abstract] [Full Text] [Related]
14. And the beat goes on: formulary restriction, generic substitution, prior authorization, drug utilization, and now therapeutic interchange.
Burkhart CG
J Drugs Dermatol; 2004; 3(1):11. PubMed ID: 14964740
[No Abstract] [Full Text] [Related]
15. The Ohio Generic Product Selection Law: influence on pharmacy practice.
Hunter RH
Med Mark Media; 1979 Jul; 14(7):33-6. PubMed ID: 10243269
[No Abstract] [Full Text] [Related]
16. Your ticket to fast, flawless prescribing.
Chesanow N
Med Econ; 2000 Oct; 77(20):93-6, 98, 100-2 passim. PubMed ID: 11184945
[No Abstract] [Full Text] [Related]
17. Physicians' attitudes toward and knowledge about generic drug substitution.
Friedman D; Jaffe A; Steinhardt S
N Y State J Med; 1987 Oct; 87(10):539-42. PubMed ID: 3479720
[No Abstract] [Full Text] [Related]
18. "Doc, I saw this great new drug on TV...".
Lowes R
Med Econ; 1999 Apr; 76(8):71-2, 75-6. PubMed ID: 10387833
[No Abstract] [Full Text] [Related]
19. Use of "dispense-as-written" on prescriptions for targeted drugs: influence of a newsletter.
Ross MB; Volger BW; Bradley JK
Am J Hosp Pharm; 1990 Nov; 47(11):2519-20. PubMed ID: 2278265
[No Abstract] [Full Text] [Related]
20. Implementation of multiple outpatient formularies: undesirable effects.
Stein CM; Wood AJ; Pincus T
Clin Pharmacol Ther; 1997 Jan; 61(1):1-7. PubMed ID: 9024168
[No Abstract] [Full Text] [Related]
[Next] [New Search]
